Four Cases Chosen as Taxotere Bellwethers

On March 9, four representative cases were chosen as the first to be tried in a series of bellwether trials regarding Sanofi-Aventis’s Taxotere (docetaxel). The drug manufacturer currently faces over 5,600 product liability cases alleging that the drug, prescribed for treatment of breast cancer, causes... Read More